S
Sagimet Biosciences Inc. (SGMT)
NGM – Real Time Price. Currency in USD
7.06
+0.20 (2.92%)
At close: Jun 26, 2026, 4:00 PM EDT
7.06
-0.00 (-0.04%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
7.06
+0.20 (2.92%)
At close: Jun 26, 2026, 4:00 PM EDT
7.06
-0.00 (-0.04%)
After-hours: Jun 26, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $36.6M significantly exceed its total debt $39.0K, ensuring strong financial flexibility
Total current assets $107.3M exceed Total current liabilities $5.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$8.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 20.26 | 6.05 | 10 | |
| Quick ratio | 20.26 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 2M | N/A | N/A | N/A |
| Gross Profit | -130K | N/A | N/A | N/A | N/A |
| Operating Income | -31M | -31M | -54M | -57M | -49M |
| Net Income | -30M | -28M | -46M | -51M | -44M |
| EBITDA | -31M | -31M | -54M | -57M | -49M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 21.56 | 5.5 |
| Next quarter | N/A | 38.09 | 5.5 |
| Current year | N/A | 24.06 | 5.5 |
| Next year | N/A | -4.23 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -11.3 | -13.78 | 27.23 | 5.5 |
| Y/Y | 999 | 41.41 | 41.07 | 40.76 | 10 |
| 3y average | 632.67 | -22.27 | 18.27 | -27.71 | 5.3 |
| 5y average | 779.2 | -41.31 | N/A | -40.86 | 3.3 |
| Weighted average score | 6.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |